Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.

Suppr

超能文献

作者信息

Howe Charles L, Bergstrom Rachel A, Horazdovsky Bruce F

出版信息

Neurology. 2009 Oct 13;73(15):1247; author reply 1247-8. doi: 10.1212/WNL.0b013e3181b26ae6.

DOI:10.1212/WNL.0b013e3181b26ae6

PMID:19822878

Abstract

摘要

相似文献

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.

Neurology. 2009 Oct 13;73(15):1247; author reply 1247-8. doi: 10.1212/WNL.0b013e3181b26ae6.

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.皮下注射胰岛素样生长因子-1在为期两年的肌萎缩侧索硬化症试验中并无益处。

Neurology. 2008 Nov 25;71(22):1770-5. doi: 10.1212/01.wnl.0000335970.78664.36.

Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis.胰岛素样生长因子-I用于治疗肌萎缩侧索硬化症。

Amyotroph Lateral Scler. 2009 Apr;10(2):63-73. doi: 10.1080/17482960802160370.

Insulin-like growth factor system in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的胰岛素样生长因子系统

Endocr Dev. 2005;9:160-169. doi: 10.1159/000085764.

Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.重组人胰岛素样生长因子I（rhIGF-I）用于治疗肌萎缩侧索硬化症/运动神经元病。

Cochrane Database Syst Rev. 2002(3):CD002064. doi: 10.1002/14651858.CD002064.

Cochrane Database Syst Rev. 2007 Oct 17(4):CD002064. doi: 10.1002/14651858.CD002064.pub2.

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group.胰岛素样生长因子-I治疗肌萎缩侧索硬化症的安慰剂对照试验。欧洲肌萎缩侧索硬化症/胰岛素样生长因子-I研究组。

Neurology. 1998 Aug;51(2):583-6. doi: 10.1212/wnl.51.2.583.

Recombinant human insulin-like growth factor-I in ALS: description of a double-blind, placebo-controlled study. North American ALS/IGF-I Study Group.重组人胰岛素样生长因子-I治疗肌萎缩侧索硬化症：一项双盲、安慰剂对照研究的描述。北美肌萎缩侧索硬化症/胰岛素样生长因子-I研究组

Neurology. 1996 Oct;47(4 Suppl 2):S93-4; discussion S94-5. doi: 10.1212/wnl.47.4_suppl_2.93s.

Insulin-like growth factor-I: potential for treatment of motor neuronal disorders.胰岛素样生长因子-I：治疗运动神经元疾病的潜力。

Exp Neurol. 1993 Nov;124(1):73-88. doi: 10.1006/exnr.1993.1177.

A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results.肌萎缩侧索硬化症中生长激素的随机对照临床试验：临床、神经影像学和激素结果。

J Neurol. 2012 Jan;259(1):132-8. doi: 10.1007/s00415-011-6146-2. Epub 2011 Jun 25.

引用本文的文献

Type 2 diabetes mellitus, antidiabetics, and the risk of amyotrophic lateral sclerosis.2型糖尿病、抗糖尿病药物与肌萎缩侧索硬化症风险

Amyotroph Lateral Scler Frontotemporal Degener. 2025 Jul 3:1-9. doi: 10.1080/21678421.2025.2515913.

Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal Phenotype.与肌萎缩侧索硬化症逆转表型相关的遗传关联。

Neurology. 2024 Aug 27;103(4):e209696. doi: 10.1212/WNL.0000000000209696. Epub 2024 Jul 30.

Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly.老年人肌少症与生长激素和胰岛素样生长因子-1 水平的关系。

BMC Musculoskelet Disord. 2020 Apr 7;21(1):214. doi: 10.1186/s12891-020-03236-y.

Neurotrophic and Neuroregenerative Effects of GH/IGF1.GH/IGF1 的神经营养和神经再生作用。

Int J Mol Sci. 2017 Nov 17;18(11):2441. doi: 10.3390/ijms18112441.

Neuroprotective Potential of Cell-Based Therapies in ALS: From Bench to Bedside.基于细胞疗法在肌萎缩侧索硬化症中的神经保护潜力：从实验室到临床应用

Front Neurosci. 2017 Oct 24;11:591. doi: 10.3389/fnins.2017.00591. eCollection 2017.

Nuclear localized C9orf72-associated arginine-containing dipeptides exhibit age-dependent toxicity in C. elegans.核定位的 C9orf72 相关精氨酸二肽在秀丽隐杆线虫中表现出年龄依赖性毒性。

Hum Mol Genet. 2017 Dec 15;26(24):4916-4928. doi: 10.1093/hmg/ddx372.

Impaired Mitophagy Plays a Role in Denervation of Neuromuscular Junctions in ALS Mice.线粒体自噬受损在肌萎缩侧索硬化症小鼠神经肌肉接头去神经支配中起作用。

Front Neurosci. 2017 Aug 25;11:473. doi: 10.3389/fnins.2017.00473. eCollection 2017.

IGF-1R Reduction Triggers Neuroprotective Signaling Pathways in Spinal Muscular Atrophy Mice.胰岛素样生长因子-1受体减少触发脊髓性肌萎缩症小鼠的神经保护信号通路。

J Neurosci. 2015 Aug 26;35(34):12063-79. doi: 10.1523/JNEUROSCI.0608-15.2015.

The therapeutic potential of IGF-I in skeletal muscle repair.IGF-I 在骨骼肌修复中的治疗潜力。

Trends Endocrinol Metab. 2013 Jun;24(6):310-9. doi: 10.1016/j.tem.2013.03.004. Epub 2013 Apr 27.

AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice.AAV4 介导的 IGF-1 和 VEGF 在脑室系统细胞成分中的表达改善家族性 ALS 小鼠的生存结果。

Mol Ther. 2010 Dec;18(12):2075-84. doi: 10.1038/mt.2010.206. Epub 2010 Sep 21.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验